Companies making headlines before the bell:» Read More
Baxter International Inc. fell$. 23 or. 3 percent, to $76.53. Bristol-Myers Squibb Co. fell$. 08 or. 2 percent, to $48.63. Hospira fell$. 17 or. 3 percent, to $50.58.
NEW YORK— A look at New York Stock Exchange 10 most-active stocks at 1 p.m.:. AbbVie fell. 6 percent to $53.14 with 13,607,100 shares traded. Advanced Micro Devices Inc. rose 2.7 percent to $4.65 with 46,059,000 shares traded.
ZURICH, July 16- Roche's experimental drug crenezumab failed to delay a decline in thinking and memory skills in people with Alzheimer's disease, a result likely to bolster a growing belief that drugs need to be given in earlier stages of the disease to show a benefit.
ZURICH, July 16- Roche said its experimental Alzheimer's drug failed to meet its main goals in a mid-stage study, a result likely to bolster the belief that drugs need to be given in earlier stages of the disease to slow patients' decline.
Baxter International Inc. fell$. 09 or. 1 percent, to $76.67. Bristol-Myers Squibb Co. rose$. 17 or. 3 percent, to $48.88. Hospira rose$. 04 or. 1 percent, to $50.79.
Jeffrey Cummings of the Cleveland Clinic said none of the deaths seemed due to the drug and pneumonia occurred at a rate to be expected in older people. Results were revealed Wednesday at the Alzheimer's Association International Conference in Copenhagen.
July 16- The Obama administration urged Congress on Wednesday to act to stem what it described as a growing trend in which U.S. companies move their headquarters abroad to reduce their U.S. tax bills. "Congress should enact legislation immediately," Treasury Secretary Jack Lew told a business conference in New York hosted by cable television channel CNBC.
July 16- Pfizer Inc said a once-weekly dose of its drug, already approved for on-demand treatment of a blood clotting disorder, reduced bleeding rates in patients in a late-stage study.
Treasury Secretary Jack Lew has urged Congress to crack down on merger deals in which companies seek to relocate overseas to cut US taxes.
Novartis and Google have agreed to develop "smart" contact lenses to help diabetics track blood glucose levels or restore the eye's ability to focus.
Increasingly, drug makers and medical device companies have found a way to self-medicate when it comes to taxes and regulation.
Big U.S. corporations are benefiting from a "new exceptionalism," allowing them to skip out on their domestic tax bills, The Washington Post says.
July 14- Several multi-billion dollar deals and bids have made 2014 a busy year for healthcare acquisitions, despite Pfizer pulling its $118 billion offer for AstraZeneca.
*AbbVie raises bid to 53.20/ share from 51.15. *Bid comprises 24.44 stg cash and 0.8960 new AbbVie shares. LONDON, July 14- London- listed drugmaker Shire Plc succumbed to an increased 31 billion pounds takeover offer from Abbvie Inc on Monday, signaling the conclusion to a long-running courtship largely motivated by tax.
Britain is to set out proposals to force foreign buyers of key UK companies to make binding commitments to secure jobs and research budgets.
Allergan told its stockholders not to respond to Pershing Square Capital Management's proposal to replace a majority of the board.
Although treatments for Alzheimer's have struggled, drugmakers are still working in the space, with 67 medicines currently in development.
It's time for the Lightning Round. Cramer makes the call on viewer favorites.
Some of the names on the move ahead of the open.
While there are weaknesses in the alternative market of prescription drugs, the risks are not always as serious as some claim.